ArticleBMC surgery2026
Safety and feasibility of laparoscopic resection for giant hepatic hemangiomas: a retrospective cohort study.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGiant hepatic hemangiomas can cause significant symptoms or complications, and laparoscopic resection remains technically demanding. This study assessed the safety and feasibility of laparoscopic resection for giant hemangiomas.
methodsA retrospective review was conducted of all patients undergoing laparoscopic resection (LR) for giant hepatic hemangiomas between July 2021 and April 2025 at a single tertiary center. Surgical indication was based on the presence of clinically relevant symptoms reasonably attributable to the hemangioma, after exclusion of alternative causes.In selected symptomatic patients, documented tumor growth (>1 cm/year) and unfavorable anatomical location, particularly proximity to major hepatic vessels, were considered supportive factors rather than independent indications for surgery.Demographic, operative, and postoperative data were analyzed. Outcomes were compared by tumor location (left vs right hepatic lobe) using the Mann–Whitney U test, with effect sizes expressed as Hodges–Lehmann median differences.
resultsEighteen patients (83% female; median age 52 years) underwent laparoscopic resection with no conversions to open surgery. Median tumor size was 100 [IQR 90–140]. Median operative time was 227.5 [IQR 181.25–262.5], median blood loss 400 [IQR 325–575] and hospital stay 4.5 [IQR 4.0–5.0]. One minor postoperative complication classified as Clavien–Dindo grade II was observed. There were no major complications and no 90-day mortality. Operative time was significantly longer for right-lobe tumors (median 238 min [IQR 217–298]) vs left-lobe tumors (173 min [IQR 156–215]; Hodges–Lehmann difference 70 min, 95% CI 0–140; p = 0.049). Blood loss was higher in the right-lobe group (median 450 vs 350 ml), but this did not reach significance (p = 0.20). No recurrences were observed during follow-up (median 10 months).
conclusionsLaparoscopic resection of giant hepatic hemangiomas appeared to be feasible and safe in selected patients in this single-center experience. Right-lobe tumors were associated with longer operative times, reflecting greater technical complexity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.